Hrt Financial LP Cardiff Oncology, Inc. Transaction History

Hrt Financial LP

  • $12.8 Billion
  • Q1 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$1.46 - $5.91 $99,117 - $401,223
67,889 New
67,889 $362,000
Q2 2021

Aug 16, 2021
SELL
$6.65 - $10.04 $1.89 Million - $2.85 Million
-283,885 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$9.1 - $19.57 $2.58 Million - $5.56 Million
283,885 New
283,885 $2.63 Million

Others Institutions Holding CRDF

# of Institutions
124
Shares Held
29M
Call Options Held
900K
Put Options Held
234K
View Full List

About Cardiff Oncology, Inc.

CRDF Quotes by TradingView
  • Ticker CRDF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,334,900
  • Market Cap $148M
  • Description
  • Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...
More about CRDF
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email